Are quantitative results of serum specific IgE assays clinically meaningful?;Quelle valeur clinique accorder aux résultats chiffrés des dosages d'IgE spécifiques?

Immuno-Analyse et Biologie Specialisee

Volumn 18, Issue 3, 2003, Pages 144-151

  Malandain, H ^a  

^a Centre Hospitalier Chubert   (France)

Author keywords

Allergy; Diagnosis; Result interpretation; Risk curves; Specific IgE

Indexed keywords

IMMUNOGLOBULIN E;

ALLERGY; ALLERGY TEST; CLINICAL IMMUNOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; HUMAN; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT;

EID: 1142273514     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2532(03)00047-4     Document Type: Article

References (47)

1. Ahlstedt S. Understanding the usefulness of specific IgE blood tests in allergy. Clin Exp Allergy. 32:2002;11-16.
2. Sampson H.A. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol. 107:2001;891-896.
3. Yunginger J.W., Ahlstedt S., Eggleston P.A., Homburger H.A., Nelson H.S., Ownby D.R., et al. Quantitative IgE antibody assays in allergic diseases. J Allergy Clin Immunol. 105:2000;1077-1084.
4. Pastorello E.A., Farioli L., Pravettoni V., Ortolani C., Ispano M., Monza M., et al. The major allergen of peach (Prunus persica) is a lipid transfer protein. J Allergy Clin Immunol. 103:1999;520-526.
5. Blanco C., Diaz-Perales A., Collada C., Sanchez-Monge R., Aragoncillo C., Castillo R., et al. Class I chitinases as potential panallergens involved in the latex-fruit syndrome. J Allergy Clin Immunol. 103:1999;507-513.
6. Pastorello E.A., Pravettoni V., Farioli L., Ispano M., Fortunato D., Monza M., et al. Clinical role of a lipid transfer protein that acts as a new apple-specific allergen. J Allergy Clin Immunol. 104:1999;1099-1106.
7. Fernández-Rivas M., Van Ree R., Cuevas M. Allergy to Rosaceae fruits without related pollinosis. J Allergy Clin Immunol. 100:1997;728-733.
8. Halmerbauer G., Hauk P., Forster J., Urbanek R., Kaufmehl K., Koller D.Y. In vivo histamine release during the first minutes after deliberate sting challenges correlates with the severity of allergic symptoms. Pediatr Allergy Immunol. 10:1999;53-57.
9. Sampson H.A., Ho D.G. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol. 100:1997;444-451.
10. Wolkerstorfer A., Wahn U., Kjellman N.I., Diepgen T.L., De Longueville M., Oranje A.P. Natural course of sensitization to cow's milk and hen's egg in childhood atopic dermatitis: ETAC Study Group. Clin Exp Allergy. 32:2002;70-73.
11. Lüttkopf D., Ballmer-Weber B.K., Wüthrich B., Vieths S. Celery allergens in patients with positive double-blind placebo-controlled challenge. J Allergy Clin Immunol. 106:2000;390-399.
12. Ballmer-Weber B.K., Hoffmann A., Wüthrich B., Lüttkopf D., Pompei C., Wangorsch A., et al. Influence of food processing on the allergenicity of celery: DBPCFC with celery spice and cooked celery in patients with celery allergy. Allergy. 57:2002;228-235.
13. Pasini G., Simonato B., Curioni A., Vincenzi S., Cristaudo A., Santucci B., et al. IgE-mediated allergy to corn: a 50 kDa protein, belonging to the Reduced Soluble Proteins, is a major allergen. Allergy. 57:2002;98-106.
14. Pastorello E.A., Vieths S., Pravettoni V., Farioli L., Trambaioli C., Fortunato D., et al. Identification of hazelnut major allergens in sensitive patients with positive double-blind, placebo-controlled food challenge results. J Allergy Clin Immunol. 109:2002;563-570.
15. Roehr C.C., Reibel S., Ziegert M., Sommerfeld C., Wahn U., Niggemann B. Atopy patch tests, together with determination of IgE levels, reduce the need for oral food challenges in children with atopic dermatitis. J Allergy Clin Immunol. 107:2001;548-553.
16. Rancé F., Dutau G., Abbal M. Mustard allergy in children. Allergy. 55:2000;496-500.
17. Niederberger V., Stubner P., Spitzauer S., Kraft D., Valenta R., Ehrenberger K., et al. Skin test results but not serology reflect immediate type respiratory sensitivity: a study performed with recombinant allergen molecules. J Invest Dermatol. 117:2001;848-851.
18. Ebner C., Siemann U., Bohle B., Willheim M., Wiedermann U., Schenk S., et al. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin Exp Allergy. 27:1997;1007-1015.
19. Jacobsen L., Nuchel Petersen B., Wihl J.A., Lowenstein H., Ipsen H. Immunotherapy with partially purified and standardized tree pollen extracts, IV. Results from long-term (6 year) follow-up. Allergy. 52:1997;914-920.
20. Oehling A.K., Sanz M.L., Resano A. Importance of IgG4 determination in in vitro immunotherapy follow-up of inhalant allergens. J Investig Allergol Clin Immunol. 8:1998;333-339.
21. Ohashi Y., Nakai Y., Tanaka A., Kakinoki Y., Washio Y., Kato A., et al. Serologic study of the working mechanisms of immunotherapy for children with perennial allergic rhinitis. Arch Otolaryngol Head Neck Surg. 124:1998;1337-1346.
22. Witteman A.M., Stapel S.O., Perdok G.J., Sjamsoedin D.H., Jansen H.M., Aalberse R.C., et al. The relationship between RAST and skin test results in patients with asthma or rhinitis: a quantitative study with purified major allergens. J Allergy Clin Immunol. 97:1996;16-25.
23. o309.
24. Guérin B., Didierlaurent A., Derer M., Stadler B. Seuil de positivité - Interprétation des résultats du RAST. Rev Fr Allergol. 25:1985;189-195.
25. Pauli G. Allergènes et allergies croisées:implications présentes et futures. Rev Fr Allergol. 38:1998;13-19.
26. Mari A., Iacovacci P., Afferni C., Barletta B., Tinghino R., Di Felice G., et al. Specific IgE to cross-reactive carbohydrate determinants strongly affects the in vitro diagnosis of allergic diseases. J Allergy Clin Immunol. 103:1999;1005-1011.
27. Aalberse R.C. Clinical relevance of carbohydrate allergen epitopes. Allergy. 53:(Suppl. 45):1998;54-57.
28. Yeang H.Y. Prevalence of latex may be vastly overestimated when determined by in vitro assays. Ann Allergy Asthma Immunol. 84:2000;628-632.
29. Hemmer W., Focke M., Kolarich D., Wilson I.B.H., Altmann F., Wöhrl S., et al. Antibody binding to venom carbohydrates is a frequent cause for double positivity to honeybee and yellow jacket venom in patients with stinging-insect allergy. J Allergy Clin Immunol. 108:2001;1045-1052.
30. Thomas W.R., Smith W. How good are carbohydrates as allergens? Clin Exp Allergy. 32:2002;658-661.
31. Hill D.J., Hosking C.S., Reyes-Benito L.V. Reducing the need for food allergen challenges in young children: a comparison of in vitro with in vivo tests. Clin Exp Allergy. 31:2001;1031-1035.
32. Garcia-Ara C., Boyano-Martinez T., Diaz-Pena J.M., Martin-Munoz F., Reche-Frutos M., Martin-Esteban M. Specific IgE levels in the diagnosis of immediate hypersensitivity to cows' milk protein in the infant. J Allergy Clin Immunol. 107:2001;185-190.
33. Boyano-Martinez T., Garcia-Ara C., Diaz-Pena J.M., Munoz F.M., Garcia Sanchez G., Martin-Esteban M. Validity of specific IgE antibodies in children with egg allergy. Clin Exp Allergy. 31:2001;1464-1469.
34. Paganelli R., Ansotegui I.J., Sastre J., Lange C.E., Roovers M.H., De Groot H., et al. Specific IgE antibodies in the diagnosis of atopic disease, Clinical evaluation of a new in vitro test system, UniCAP, in six European allergy clinics. Allergy. 53:1998;763-768.
35. Rancé F., Abbal M., Lauwers-Cancès V. Improved screening for peanut allergy by the combined use of skin prick tests and specific IgE assays. J Allergy Clin Immunol. 109:2002;1027-1033.
36. Sigurs N., Hattevig G., Kjellman B., Kjellman N.I., Nilsson L., Bjorksten B. Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4 to 15 years. J Allergy Clin Immunol. 94:1994;757-763.
37. Sasai K., Furukawa S., Muto T., Baba M., Yabuta K., Fukuwatari Y. Early detection of specific IgE antibody against house dust mite in children at risk of allergic disease. J Pediatr. 128:1996;834-840.
38. Kulig M., Bergmann R., Klettke U., Wahn V., Tacke U., Wahn U. Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol. 103:1999;1173-1179.
39. Sensi L.G., Piacentini G.L., Nobile E., Ghebregzabher M., Brunori M., Zamolla L., et al. Changes in nasal specific IgE to mites after periods of allergen exposure avoidance: a comparison with serum levels. Clin Exp Allergy. 24:1994;331-341.
40. Hamilton R.G., Brown R.H. Natural history of latex allergy in sensitized healthcare workers (HCWs). J Allergy Clin Immunol. 103:1999;S52.
41. Ylitalo L., Alenius H., Turjanmaa K., Palosuo T., Reunala T. Natural rubber latex allergy in children: a follow-up study. Clin Exp Allergy. 30:2000;1611-1617.
42. De Blay F., Zana H., Offner M., Verot A., Velten M., Pauli G. Receiver operating characteristic analysis: a useful method for a comparison of the clinical relevance of two in vitro IgE tests. J Allergy Clin Immunol. 92:1993;255-263.
43. Dolen W.K. Detection limits and receiver operating characteristic curve analysis in the evaluation of specific IgE assays. Allergy Proc. 15:1994;319-322.
44. Corey J.P., Mamikoglu B., Akbar I., Houser S.M., Gungor A. ImmunoCAP and HY*TEC enzyme immunoassays in the detection of allergen-specific IgE compared with serial skin end-point titration by receiver operating characteristic analysis. Otolaryngol Head Neck Surg. 122:2000;64-70.
45. Biagini R.E., Krieg E.F., Pinkerton L.E., Hamilton R.G. Receiver operating characteristics analyses of Food and Drug Administration-cleared serological assays for natural rubber latex-specific immunoglobulin E antibody. Clin Diagn Lab Immunol. 8:2001;1145-1149.
46. Plebani M., Borghesan F., Basso D., Faggian D. Receiver-operating characteristic (ROC) curves: a fundamental tool for improving the clinical usefulness of in vitro IgE tests. Allergy. 51:1996;407-411.
47. Hiller R., Laffer S., Harwanegg C., Huber M., Schmidt W.M., Twardosz A., et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J. 16:2002;414-416.